Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition
Mao, Wendy, Ghasemzadeh, Ali, Freeman, Zachary T., Obradovic, Aleksandar, Chaimowitz, Matthew G., Nirschl, Thomas R., McKiernan, Emily, Yegnasubramanian, Srinivasan, Drake, Charles G.Volume:
7
Language:
english
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1186/s40425-019-0758-y
Date:
December, 2019
File:
PDF, 1.74 MB
english, 2019